Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Disease × Calcium Dobesilate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Multiple Myeloma 13 Leukemia 10 Burkitt Lymphoma 7 Lymphoma 5 Lung Neoplasms 3 Leukemia, Biphenotypic, Acute 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Immunoglobulin Light-chain Amyloidosis 2 Hodgkin Disease 2 Carcinoma, Non-Small-Cell Lung 2 Vomiting 1 Smoldering Multiple Myeloma 1 Recurrence 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neoplasms, Neuroepithelial 1 Nausea 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Down Syndrome 1 Disease 1 Colorectal Neoplasms 1 Brenner Tumor 1 Astrocytoma 1

Interventions

Cyclophosphamide 3 carfilzomib 2 Dexamethasone 2 deltacortene 1 daratumumab 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Calcium Dobesilate 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01857115 2024-11-13

wCCyd

European Myeloma Network B.V.

Phase 1/2 Completed

Disease, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡